Europe Benign Prostatic Hyperplasic Devices Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Benign Prostatic Hyperplasic Devices Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Benign Prostatic Hyperplasic Devices Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Benign Prostatic Hyperplasic Devices Market Regional Analysis

6.2 Europe Benign Prostatic Hyperplasic Devices Market Revenue 2020-2028 (US$ Million)

6.3 Europe Benign Prostatic Hyperplasic Devices Market Forecast Analysis

7. Europe Benign Prostatic Hyperplasic Devices Market Analysis – by Product

7.1 Resectoscopes

7.1.1 Overview
7.1.2 Resectoscopes: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Urology Laser

7.2.1 Overview
7.2.2 Urology Laser: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Radiofrequency Ablation Devices

7.3.1 Overview
7.3.2 Radiofrequency Ablation Devices: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.4 Prostatic Stents

7.4.1 Overview
7.4.2 Prostatic Stents: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.5 Implants

7.5.1 Overview
7.5.2 Implants: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Benign Prostatic Hyperplasic Devices Market Analysis – by Procedure Type

8.1 Transurethral Microwave Therapy

8.1.1 Overview
8.1.2 Transurethral Microwave Therapy: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Transurethral Resection of the Prostate

8.2.1 Overview
8.2.2 Transurethral Resection of the Prostate: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Transurethral Needle Ablation of the Prostate

8.3.1 Overview
8.3.2 Transurethral Needle Ablation of the Prostate: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Laser Surgery

8.4.1 Overview
8.4.2 Laser Surgery: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Urolift Surgery

8.5.1 Overview
8.5.2 Urolift Surgery: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Benign Prostatic Hyperplasic Devices Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Clinics

9.2.1 Overview
9.2.2 Clinics: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Ambulatory Surgical Centers

9.3.1 Overview
9.3.2 Ambulatory Surgical Centers: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Europe Benign Prostatic Hyperplasic Devices Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 UK: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
10.2.1.1.2 UK: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
10.2.1.1.3 UK: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User

10.2.1.2 Germany: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Germany: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
10.2.1.2.2 Germany: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
10.2.1.2.3 Germany: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User

10.2.1.3 France: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 France: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
10.2.1.3.2 France: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
10.2.1.3.3 France: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User

10.2.1.4 Russia: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Russia: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
10.2.1.4.2 Russia: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
10.2.1.4.3 Russia: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User

10.2.1.5 Italy: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Italy: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
10.2.1.5.2 Italy: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
10.2.1.5.3 Italy: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
10.2.1.6.2 Rest of Europe: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
10.2.1.6.3 Rest of Europe: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 KARL STORZ SE & Co. KG

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Olympus Corporation

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Boston Scientific Corporation

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Teleflex Incorporated

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Richard Wolf GmbH

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 GmbH

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Benign Prostatic Hyperplasic Devices Market